BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8516939)

  • 1. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 2. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
    Wang M; Tu Y; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
    [No Abstract]   [Full Text] [Related]  

  • 6. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
    Lin Y; Rutgeerts O; Waer M
    Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
    [No Abstract]   [Full Text] [Related]  

  • 7. Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.
    Collins BH; Areford ML; Fabian MA; Jaffee BD; Bollinger RR
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):37-9. PubMed ID: 8516941
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Smith S; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H; Wu J; Luo H; Daloze P
    Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A; Plenter R; Francis DM; Clunie GJ
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.
    Knight R; Ferraresso M; Serino F; Katz S; Lewis R; Kahan BD
    Transplantation; 1993 Apr; 55(4):947-9. PubMed ID: 8475571
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
    Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
    Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of diltiazem and rapamycin on survival of rat cardiac allografts.
    Dumont L; Chen H; Xu D; Daloze P
    Ann N Y Acad Sci; 1993 Nov; 696():392-5. PubMed ID: 8109847
    [No Abstract]   [Full Text] [Related]  

  • 16. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination.
    Kahan BD; Tejpal N; Gibbons-Stubbers S; Tu Y; Wang M; Stepkowski S; Chou TC
    Transplantation; 1993 Apr; 55(4):894-900. PubMed ID: 8475566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM; Chen H; Daloze P; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
    Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
    Asano T; Murai M; Nakamura H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP; Morris RE
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.